Cerulean Pharma reported $-12668940 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Agile Therapeutics AGRX:US -15774000 877K
Arrowhead Research ARWR:US $ -64883000 33.02M
Bayer BAYN:GR 530M 2.81B
Biocept BIOC:US $ 0.5M 2.25M
Brainstorm Cell Therapeutics BCLI:US $ -5277000 844K
Cerulean Pharma CERU:US $ -12668940 3.51M
Immunogen IMGN:US $ -34.23M 6.86M
Johnson & Johnson JNJ:US $ 3849M 2813M
Macrogenics MGNX:US $ -52987000 12.71M
Merk MRK:US $ 4826M 3212M
Nektar Therapeutics NKTR:US $ -113.6M 3.39M
Perrigo Ordinary Shares PRGO:US $ 438.3M 564.2M
Pfizer PFE:US $ 7647M 1733M
Seattle Genetics SGEN:US $ -297.96M 208.36M
YTE INCY:US $ 235.41M 94.57M